Engineered to meet the stringent biomechanical standards of Switzerland's leading orthopedic centers, offering superior fixation strength and clinical efficiency.
Switzerland represents the global epicenter of medical device engineering, boasting clusters in Zurich, Neuchâtel, Solothurn, and Geneva that produce the world’s most advanced orthopedic implants. The Swiss medtech ecosystem demands ultra-precise manufacturing, biocompatible material compliance, and relentless quality control. However, rising domestic operational and labor costs have accelerated the shift toward high-performance hybrid manufacturing alliances. Swiss-based distributors, brand owners, and procurement groups increasingly seek strategic production partners who can balance precision machining with agile scalability.
Regulatory changes present further challenges. With the implementation of the European Union Medical Device Regulation (EU MDR 2017/745) and the termination of the EU-Swiss Mutual Recognition Agreement (MRA) update, Swiss manufacturers and distributors must navigate complex compliance routes under Swissmedic supervision. Adapting to these strict frameworks requires orthopedic devices that carry complete technical documentation, validated biocompatibility profiles, and traceabilities that exceed basic regulatory thresholds.
The future of sports medicine reconstruction revolves around tissue preservation, rapid osseointegration, and minimally invasive deployment. Manufacturers targeting advanced markets are shifting from permanent metal implants to high-performance polymers and bio-absorbable composites. Materials like PEEK (Polyetheretherketone) provide elastic modulus profiles that closely mimic human cortical bone, reducing stress-shielding and improving postoperative imaging clarity.
Our technology roadmap prioritizes key innovations:
Developed for anatomically demanding procedures in sports medicine, ensuring high primary stability and tension retention.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands.
With a customer-oriented philosophy, competitive pricing, stable supply capability, and efficient technical support, Synoviq has established long-term partnerships with distributors, medical brands, and healthcare organizations across Europe, North America, South America, the Middle East, and Asia-Pacific. We strive to act as a trusted international partner in the orthopedic medical device industry.
| Capability Indicator | Technical & Operational Specifications |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand | Synoviq |
| Established | March 18, 2016 |
| Building Area | 18,600 m² |
| Annual Export Revenue | USD 21.8 Million |
| Export & Industry Experience | 8 Years Export / 14 Years Industry Specialization |
| Quality Control Standard | 100% Final Inspection & Incoming Material Inspection (48 QC Staff) |
| Inspection Protocol | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation |
| Main Markets | Europe (including Switzerland), North America, South America, Middle East, Southeast Asia |
| Supply Chain Network | 1,120+ Audited Raw Material & Logistic Partners |
| R&D Resources | 76 In-house R&D Engineers, 186 New Products Released Last Year |
Inside Synoviq's ISO-compliant facilities: modern CNC platforms, cleaning stations, and material analysis testing laboratories.
Operating an 18,600 m² modern manufacturing footprint, Synoviq utilizes Industry 4.0 manufacturing processes to ensure stability in the medical supply chain. By integrating multi-axis CNC Swiss-type lathes, automated wire EDM, and laser-welding work cells, we achieve dimensional dimensional tolerances down to ±0.005mm. This degree of automation allows us to produce large quantities of components without sacrificing structural performance.
For Swiss distributors and brand owners, this manufacturing model offers a strategic advantage. It balances high-precision engineering with competitive manufacturing costs. By managing raw materials (Grade 5 Titanium ELI and PEEK-OPTIMA) and using advanced polishing and electrochemical passivation techniques, we reduce unit production costs. This enables our partners to optimize operating margins while complying with strict hospital tender requirements in Europe.
OEM/ODM collaboration in sports medicine implants requires meeting strict technical standards. Enterprise procurement teams, particularly those in the Swiss and larger European markets, focus on specific key areas during supplier evaluations:
Technical information on regulatory compliance, OEM customization, and materials for sports medicine components.
Our comprehensive range of implants and instruments designed for knee, shoulder, and extremities repair.
Request physical samples, technical drawings, or arrange an audit of our 18,600 m² cleanroom manufacturing facility.
Send Inquiry Now
Synoviq Medical